Navigation Links
Enzyme Urokinase Better Option In Empyema For Kids

Researchers say that enzyme urokinase provides a better option as a treatment for empyema in children since it is 25 percent less costlier than another treatment// video-assisted thoracoscopic surgery. The researchers say both methods are equally effective.

The study results appear in the second issue for July 2006 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

Samatha Sonnappa, M.D., of the Portex Respiratory Unit at the Institute of Child Health in London, and seven associates studied 60 children with empyema, which involves pus from pneumonia infecting the pleural membrane lining the lung walls. Thirty children were treated with chest drainage using intrapleural urokinase, and 30 underwent video-assisted thorascopic surgery for the problem. The average age of the patients was 3-1/2.

The pleura is a very thin, transparent membrane that covers the lungs and lines the inside of the chest wall. Empyema occurs when pus from pneumonia or a lung abscess spreads into the pleural space. About 0.6 percent of childhood pneumonia progresses to empyema.

The aim of treatment in empyema is to sterilize the pleural cavity, reduce fever and ensure the full expansion of the lung so it can return to normal function, said Dr. Sonnappa. Our study is the first randomized prospective trial to compare chest drain against primary video-assisted thorascopic surgery for the treatment of empyema in children.

No significant clinical differences were found between each treatment group in terms of length of hospital stay after intervention, failure rate of the procedure or radiologic outcome at 6 months after the procedure.

An important observation is that video-assisted thorascopic surgery is $2,250 or 25 percent more expensive than intrapleural urokinase at our center without including start-up costs for the provision of surgery, said Dr. Sonnappa. Also, a m ajor limitation of the surgical procedure is that it is highly dependent on the skill of the operator. Poor results in some centers have been reported, and surgical expertise to perform pediatric video-assisted thorascopic surgery is limited to a few major centers in the United Kingdom.

The researchers estimated that in 2005, the number of pneumonia cases that progressed to empyema was approximately 6,600 in the U.S. and 1,080 in the U.K. If intrapleural urokinase was used as the first line of treatment for pediatric empyema in each of these cases, it would have resulted in a health care savings of $15 million in the U.S., and $2.5 million in the U.K.

In an editorial on the research in the same issue of the journal, Julian L. Allen, M.D., and Peter Mattei M.D., of the Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, wrote: The authors are to be congratulated in designing and carrying out this careful study. One would certainly say that, on a cost basis, urokinase is the better choice if the therapies are equivalent in every other way. However, their recommendations that urokinase is the treatment of choice depends on the clinical equipoise (equilibrium) that their study demonstrated.

One concern about this study is that while groups treated with video-assisted thorascopic surgery and fibrinolysis are closely matched, there may have been small differences. The editorialists then noted that certain findings seem to point to slightly worse disease in the surgical study group. Also, since certain clinical factors were not reported by the researchers, there could be even more distinguishing characteristics between the two treatment groups.

A second concern is that the length of stay after intervention, total length of stay and failure rates are surrogate outcomes, subjectively determined by the attending physician, who is not blinded to the treatment arm. Other important outcomes in clude the following: the amount of pain associated with the intervention and long-term physiologic outcomes such as pulmonary function and exercise tolerance. These variables are certainly more important than a $2,000 difference in cost.

The above notwithstanding, the study by Drs. Sonnappa and colleagues is clearly a helpful step in the direction of providing needed insight into the management of pleural infection in children.

Source: Eurekalert
'"/>




Related medicine news :

1. Enzyme may be target for obesity drugs
2. Researchers trick Alzheimers Enzyme
3. Enzyme stimulates growth of adult stem cells
4. Enzyme may aid hold back disease
5. Enzyme help destroy cancer cell
6. Enzyme Associated with Memory
7. Enzyme Associated With Memory
8. Brain Enzyme Found To Regulate Weight
9. New Enzyme Identified For Arthritis
10. Enzyme for treatment of arthritis
11. An Enzyme That Turns a One –time Experience into a long-time Memor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2016)... Bay, Jamaica (PRWEB) , ... April 30, 2016 ... ... University, and Duane Boise, President and CEO of EMED, today signed a multifaceted ... Jamaica. , EMED and the Northern Caribbean University Department of Natural and Applied ...
(Date:4/29/2016)... ... April 30, 2016 , ... Mercy College is expanding its Graduate Business Programs ... be expanding due to high demand: Master of Business Administration (MBA), Master of Organizational ... , School of Business Graduate Program Chair Dr. Ray Manganelli said: “We ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded daily ... confront and deal with these stressors is to adopt a more healthful diet, but ... you. Risa Groux, a certified Holistic Nutritionist and the creator of the Newport Beach ...
(Date:4/29/2016)... ... 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd annual ... skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers and ... Walk and 1-mile walk were held to increase awareness about Lyme disease and ...
(Date:4/29/2016)... City, Missouri (PRWEB) , ... April 29, 2016 , ... ... traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes body ... strain on their wrists and hands when using the crutches than with other crutches. ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
(Date:4/27/2016)... 27, 2016 Global  urinalysis ... billion by 2022, according to a new report ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... efficiency and accuracy delivered by the new generation ... novel urinalysis instruments and consumables. For instance, the ...
(Date:4/26/2016)... Hill-Rom Holdings, Inc. (NYSE: HRC ) invites you ... 41 st Annual Health Care Conference on Wednesday, May ... invited to listen to the live discussion via the internet ... http://edge.media-server.com/m/p/mr4uxgas . A recorded replay of the discussion will ... and accessible at the links above until August 1, 2016. ...
Breaking Medicine Technology: